Alina M. Allen

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year‐community study

Alina M. Allen, Terry M. Therneau, Joseph J. Larson et al. · Hepatology · 2017 · 365 citations

The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity – A longitudinal cohort study

Alina M. Allen, Stephen B. Hicks, Kristin C. Mara et al. · Journal of Hepatology · 2019 · 303 citations · Full text

Obesity, Metabolic Syndrome, Longitudinal Cohort Study +13

Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement

Hannes Hagström, Leon A. Adams, Alina M. Allen et al. · Hepatology · 2021 · 231 citations · Full text

Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease

Ju Dong Yang, Fowsiyo Ahmed, Kristin C. Mara et al. · Hepatology · 2019 · 199 citations · Full text

Hcc Risk, Cirrhosis Development, Pathology +23